Revelation Biosciences, Inc. (NASDAQ:REVBW) Short Interest Down 97.6% in May

Revelation Biosciences, Inc. (NASDAQ:REVBW) saw a significant decline in short interest in the month of May. As of May 15th, there was short interest totaling 1,162 shares, a decline of 97.6% from the April 30th total of 48,365 shares. Based on an average trading volume of 202,279 shares, the days-to-cover ratio is currently 0.0 days.

Revelation Biosciences Trading Up 19.6%

Shares of Revelation Biosciences stock traded up $0.00 during trading on Thursday, reaching $0.01. The company’s stock had a trading volume of 13,238 shares, compared to its average volume of 90,231. The business’s 50-day moving average price is $0.01 and its 200-day moving average price is $0.01. Revelation Biosciences has a 52 week low of $0.01 and a 52 week high of $0.04.

About Revelation Biosciences

Revelation Biosciences, Inc (NASDAQ: REVBW) is a clinical-stage molecular diagnostics company focused on the rapid detection of life-threatening bacterial infections. The company leverages next-generation sequencing (NGS) to analyze cell-free microbial DNA in patient blood samples, with an emphasis on early identification of pathogens in bloodstream infections and hospital-acquired pneumonia. By targeting critically ill patients, Revelation Biosciences aims to shorten time to diagnosis and guide more effective antimicrobial therapy.

The company’s technology platform integrates high-throughput DNA sequencing with proprietary bioinformatics algorithms to differentiate pathogenic microbes from background microbial DNA.